168 related articles for article (PubMed ID: 18997102)
1. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
Ayala I; Castillo AM; Adánez G; Fernández-Rufete A; Pérez BG; Castells MT
Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
[TBL] [Abstract][Full Text] [Related]
2. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.
Martín-Castillo A; Castells MT; Adánez G; Polo MT; Pérez BG; Ayala I
Biomed Pharmacother; 2010 Apr; 64(4):275-81. PubMed ID: 19932590
[TBL] [Abstract][Full Text] [Related]
3. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
Murayama H; Ikemoto M; Nagata A
J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
[TBL] [Abstract][Full Text] [Related]
4. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
6. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
Kuzu N; Bahcecioglu IH; Dagli AF; Ozercan IH; Ustündag B; Sahin K
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e465-70. PubMed ID: 17683497
[TBL] [Abstract][Full Text] [Related]
8. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
[TBL] [Abstract][Full Text] [Related]
9. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
[TBL] [Abstract][Full Text] [Related]
10. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.
El Bassat H; Ziada DH; Hasby EA; Nagy H; Abo Ryia MH
Arab J Gastroenterol; 2014 Mar; 15(1):6-11. PubMed ID: 24630506
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice.
Wouters K; van Bilsen M; van Gorp PJ; Bieghs V; Lütjohann D; Kerksiek A; Staels B; Hofker MH; Shiri-Sverdlov R
FEBS Lett; 2010 Mar; 584(5):1001-5. PubMed ID: 20114046
[TBL] [Abstract][Full Text] [Related]
13. Clerodendron glandulosum.Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis.
Jadeja RN; Thounaojam MC; Dandekar DS; Devkar RV; Ramachandran AV
Food Chem Toxicol; 2010 Dec; 48(12):3424-31. PubMed ID: 20849909
[TBL] [Abstract][Full Text] [Related]
14. The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet.
Fan J; Zhong L; Wang G; Wu X; Li M; Jing D; Zhang P
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):16-8. PubMed ID: 11242127
[TBL] [Abstract][Full Text] [Related]
15. Psammomys obesus (sand rat), a new animal model of non-alcoholic fatty liver disease.
Maislos M; Medvedovskv V; Sztarkier I; Yaari A; Sikuler E
Diabetes Res Clin Pract; 2006 Apr; 72(1):1-5. PubMed ID: 16242203
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
[TBL] [Abstract][Full Text] [Related]
17. Liver biopsy in alcoholic and non-alcoholic steatohepatitis patients.
Tiniakos DG
Gastroenterol Clin Biol; 2009; 33(10-11):930-9. PubMed ID: 19646834
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and identification of non-alcoholic fatty liver disease in chronic hepatitis B virus infected mice].
Zhang Z; Pan Q; Duan XY; Shi JP; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):658-63. PubMed ID: 22152379
[TBL] [Abstract][Full Text] [Related]
19. Animal models of NASH: getting both pathology and metabolic context right.
Larter CZ; Yeh MM
J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia.
Sturzeneker MC; Ioshii SO; Villela Baroncini LA; Précoma DB
Atherosclerosis; 2011 May; 216(1):97-102. PubMed ID: 21338989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
